0001703978-21-000002.txt : 20210726 0001703978-21-000002.hdr.sgml : 20210726 20210726081857 ACCESSION NUMBER: 0001703978-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210726 DATE AS OF CHANGE: 20210726 EFFECTIVENESS DATE: 20210726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: biOasis Technologies Inc. CENTRAL INDEX KEY: 0001703978 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-407668 FILM NUMBER: 211112513 BUSINESS ADDRESS: STREET 1: 14 WATER STREET CITY: GUILFORD STATE: CT ZIP: 06437 BUSINESS PHONE: 1-203-390-7395 MAIL ADDRESS: STREET 1: 14 WATER STREET CITY: GUILFORD STATE: CT ZIP: 06437 D 1 primary_doc.xml X0708 D LIVE 0001703978 biOasis Technologies Inc. 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 203 533-7082 BRITISH COLUMBIA, CANADA W.R. Partners Ltd. None Corporation true Dave P. Jenkins 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Executive Officer Deborah Rathjen 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Executive Officer Director Mei Mei Tian 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Executive Officer May Orfali 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Executive Officer John E. Curran 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Director John Hemeon 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Director Mario Saltarelli 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Director David M. Wurzer 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Director Biotechnology $1 - $1,000,000 06b false 2021-06-28 true true true true true The offering includes (i) warrants, each exercisable for one common share at CAD$0.41 for a period of 30 months, and (ii) a convertible security with an aggregate face value of CAD$3,600,000, subject to a hold period of four months and one day. false 0 4526964 2918525 1608439 The additional $1,608,439.00 may be received upon the exercise of warrants sold inside or outside the U.S. The U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on June 28, 2021, which was CAD$1.2335=USD$1.00. false 1 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false biOasis Technologies Inc. Deborah Rathjen Deborah Rathjen Chief Executive Officer and Executive Chairman 2021-07-26